Вестник трансплантологии и искусственных органов (Jun 2009)

CLINICAL EFFICACY OF ALBUMIN DIALYSIS THERAPY FOR PATIENTS WITH HEPATORENAL SYNDROME

  • D. E. Kutepov,
  • I. N. Pasechnik,
  • N. P. Mironov,
  • E. V. Tsygankov,
  • A. V. Popov,
  • O. K. Morochova,
  • S. V. Stebletsov,
  • E. Y. Kotselapova,
  • M. G. Vershinina

DOI
https://doi.org/10.15825/1995-1191-2009-4-51-56
Journal volume & issue
Vol. 11, no. 4
pp. 51 – 56

Abstract

Read online

34 patients (23 male, 11 female) in the age of 41–77 years (mean age 59,7 ± 4,2 years) with 2 type hepatorenal syndrome were included in the study. All patients were divided in 3 groups. The 1st group (n = 15) was treated by medical treatment, the 2nd group (n = 12) was treated by medical treatment and hemodiafiltration and the 3rd group (n = 7) – combined treatment with MARS therapy. Outcomes showed that combined therapy with addition of MARS provides positive results in treatment of the patients with 2 type hepatorenal syndrome.

Keywords